Health analytics marketplace Apervita, formerly known as Pervasive Health, secured the money from investors including General Electric.
US-based health analytics marketplace Apervita closed an $18m series A round co-led by GE Ventures, the corporate venturing arm of conglomerate General Electric, on Wednesday.
Venture capital and private equity firm Baird Capital co-led the round, which included funding from Pritzker Group Venture Capital, Math Ventures and undisclosed existing investors.
Apervita had targeted $26m from the round, according to a regulatory filing last month, made under its previous name of Pervasive Health. The company previously secured $1.6m in debt financing…
